ATE418544T1 - Grosstechnisches verfahren zur abtrennung und aufreinigung von fentanyl durch präparative umkehrphasenchromatographie - Google Patents

Grosstechnisches verfahren zur abtrennung und aufreinigung von fentanyl durch präparative umkehrphasenchromatographie

Info

Publication number
ATE418544T1
ATE418544T1 AT04796374T AT04796374T ATE418544T1 AT E418544 T1 ATE418544 T1 AT E418544T1 AT 04796374 T AT04796374 T AT 04796374T AT 04796374 T AT04796374 T AT 04796374T AT E418544 T1 ATE418544 T1 AT E418544T1
Authority
AT
Austria
Prior art keywords
fentanyl
purification
reverse phase
separation
phase chromatography
Prior art date
Application number
AT04796374T
Other languages
German (de)
English (en)
Inventor
Enrico Antonini
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of ATE418544T1 publication Critical patent/ATE418544T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B01J20/287—Non-polar phases; Reversed phases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT04796374T 2003-10-29 2004-10-22 Grosstechnisches verfahren zur abtrennung und aufreinigung von fentanyl durch präparative umkehrphasenchromatographie ATE418544T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51527403P 2003-10-29 2003-10-29

Publications (1)

Publication Number Publication Date
ATE418544T1 true ATE418544T1 (de) 2009-01-15

Family

ID=34572823

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04796374T ATE418544T1 (de) 2003-10-29 2004-10-22 Grosstechnisches verfahren zur abtrennung und aufreinigung von fentanyl durch präparative umkehrphasenchromatographie

Country Status (11)

Country Link
US (1) US7728145B2 (enExample)
EP (1) EP1682505B1 (enExample)
JP (1) JP2007509945A (enExample)
CN (1) CN100509785C (enExample)
AT (1) ATE418544T1 (enExample)
AU (1) AU2004287815B2 (enExample)
CA (1) CA2544195A1 (enExample)
DE (1) DE602004018674D1 (enExample)
ES (1) ES2320136T3 (enExample)
MX (1) MX264489B (enExample)
WO (1) WO2005044798A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7486949B2 (en) * 2004-03-10 2009-02-03 Broadcom Corporation Method for re-establishing telephone calls after unintended termination
CA2581863A1 (en) * 2004-11-10 2006-05-26 Boehringer Ingelheim Chemicals, Inc. Process of making fentanyl intermediates
US20100076198A1 (en) * 2008-09-19 2010-03-25 Mallinckrodt Inc. Crystalline forms of Fentanyl Alkaloid
WO2014118797A1 (en) * 2013-01-29 2014-08-07 Neuland Health Sciences Private Limited Purification of organic compounds using surrogate stationary phases on reversed phase columns
CA2924821A1 (en) * 2013-09-20 2015-03-26 Davuluri, Ramamohan Rao Purification of organic compounds by surfactant mediated preparative hplc
US20220395767A1 (en) * 2021-06-15 2022-12-15 Perkinelmer Health Sciences, Inc. Enhancing lcms analyte signals

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284196A (enExample) * 1961-10-10
US4234684A (en) * 1979-12-11 1980-11-18 Eli Lilly And Company Method of preparing mycophenolic acid glucoside
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4317903A (en) * 1981-01-26 1982-03-02 The Upjohn Company Process for the purification of lincomycin
US4336333A (en) * 1981-03-13 1982-06-22 Eli Lilly And Company Process for preparing tunicamycin
US4916142A (en) * 1987-02-02 1990-04-10 Boc, Inc. N-heterocyclic-N-(4-piperidinyl)amides and pharmaceutical compositions and their use as analgesics
US4904590A (en) * 1988-12-27 1990-02-27 Eli Lilly And Company Antibiotic A80915 and process for its production
US5780589A (en) * 1994-11-30 1998-07-14 The United States Of America As Represented By The Department Of Health And Human Services Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
WO1999039195A1 (en) * 1998-02-03 1999-08-05 Arqule, Inc. Rapid method for separation of small molecules using reverse phase high performance liquid chromatography
ES2272354T3 (es) * 1999-12-06 2007-05-01 Mallinckrodt Inc. Metodos para la sintesis de alfentanilo,sufentanilo remifentanilo.
CN1639166A (zh) * 2002-02-28 2005-07-13 马林克罗特公司 通过反相制备色谱法分离和纯化至少一种麻醉生物碱的方法和系统
ITRM20020458A1 (it) 2002-09-13 2004-03-14 Ambiotec S A S Di Ammendola Sergio Procedimento per la separazione preparativa degli epimeri di steroidi.

Also Published As

Publication number Publication date
CA2544195A1 (en) 2005-05-19
ES2320136T3 (es) 2009-05-19
US20070123710A1 (en) 2007-05-31
EP1682505B1 (en) 2008-12-24
MX264489B (en) 2009-02-12
WO2005044798A1 (en) 2005-05-19
US7728145B2 (en) 2010-06-01
MXPA06004711A (es) 2006-07-20
JP2007509945A (ja) 2007-04-19
DE602004018674D1 (de) 2009-02-05
AU2004287815A1 (en) 2005-05-19
AU2004287815B2 (en) 2009-05-28
CN1874999A (zh) 2006-12-06
CN100509785C (zh) 2009-07-08
EP1682505A1 (en) 2006-07-26

Similar Documents

Publication Publication Date Title
BRPI0518207A (pt) método de separação de um ou mais anticorpos de um ou mais outros compostos em uma amostra lìquida, kits para a purificação de anticorpos de um ou mais outros componentes em um lìquido, e para a captura de anticorpos de um ou mais outros componentes em um lìquido, coluna de cromatografia, e, filtro descartável para a purificação de anticorpos
DE59409712D1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
Keβler et al. Step gradients in 3-zone simulated moving bed chromatography: application to the purification of antibodies and bone morphogenetic protein-2
CA2214633A1 (en) Antibody purification by low-ph hydrophobic interaction chromatography
DE602005022239D1 (de) Festphase zur Verwendung in einem Verfahren zur Reinigung von Albuminkonjugaten
ATE282044T1 (de) Chromatographische reinigung von chlorinierter sukrose
ATE461199T1 (de) Verfahren zur trennung und reinigung von hydrocodon durch präparative chromatographie
DK1137663T3 (da) Oprensning af Echinocandin-cyclopeptidforbindelser
AU3273200A (en) Ion exchange chromatographic separation of glp-1 and related peptides
DE602004018674D1 (de) Grosstechnisches verfahren zur abtrennung und aufreinigung von fentanyl durch präparative umkehrphasenchromatographie
GB2437442A (en) Improved process for purification of 6 acetyl 4,1',6' trichlorogalactosucrose and 4,1',6' trichlorogalactosucrose by chromatography on silanized silica gel
WO2005026323A3 (en) Stationary phases and a purification process using the stationary phases
Hamman et al. A high throughput approach to purifying chiral molecules using 3 μm analytical chiral stationary phases via supercritical fluid chromatography
ATE438606T1 (de) Verfahren zur extrahierung, fraktionierung und reinigung mittels eines harzes mit hohem adsorptions- und eluierungsrendement, von polyphenolischen verbindungen erhalten aus ausleseabfällen von frischen gemüsen
WO2007081906A3 (en) Purification by column-chromatography using eluants containing organic solvents
DE60016222D1 (de) Verfahren zur trennung von ätherischen ölen aus ätherischen ölen enthalendem material
CA2548297A1 (en) Process for the purification of macrolides
CA2899387A1 (en) Purification of organic compounds using surrogate stationary phases on reversed phase columns
DK1064066T3 (da) Adsorptionschromatografi
SE0402558D0 (sv) A process for the purification of antibodies
SE9904272D0 (sv) A method for selective removal of a substance from samples containing compounds having nucleic acid structure
ATE509989T1 (de) Adsorber mit anthrachinonfarbstoffliganden zur trennung von biologischen stoffen
EA200700559A1 (ru) Способ разделения с помощью цеолитного материала itq-29
JP2007509945A5 (enExample)
Cao et al. Semi-preparative separation and purification of taxol analogs by high-speed countercurrent chromatography

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties